LONG MINI-FUTURE - NOVO-NORDISK B Stock

Certificat

DE000VP1SU02

Market Closed - Boerse Frankfurt Warrants 01:53:46 2024-06-14 pm EDT
21.82 EUR +1.49% Intraday chart for LONG MINI-FUTURE - NOVO-NORDISK B
Current month+9.98%
1 month+12.42%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 21.82 +1.49%
24-06-13 21.5 -0.14%
24-06-12 21.53 +0.05%
24-06-11 21.52 -1.06%
24-06-10 21.75 +0.32%

Real-time Boerse Frankfurt Warrants

Last update June 14, 2024 at 01:53 pm EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Vontobel Vontobel
WKN VP1SU0
ISINDE000VP1SU02
Date issued 2020-03-25
Strike 181.4 kr
Maturity Unlimited
Parity 5 : 1
Emission price 0.25
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 21.82
Lowest since issue 0.34

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
991 DKK
Average target price
934.3 DKK
Spread / Average Target
-5.72%
Consensus